최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기KSBB Journal, v.33 no.2, 2018년, pp.70 - 75
손다진 (강원대학교 생물공학과) , 김종석 (강원대학교 생물공학과) , 박재범 (강원대학교 생물공학과) , 권덕호 (강원대학교 생물공학과) , 정형무 (한국코러스제약) , 한상인 (한국코러스제약) , 홍억기 (강원대학교 생물공학과) , 하석진 (강원대학교 생물공학과)
Multiple sclerosis is a chronic disorder commonly occurred in the central nervous system and is an autoimmune disease. Corticosteroids are used as a short-term treatment for multiple sclerosis, but they cause side effects. Therefore, interferon beta having antiviral and anti-inflammatory effects, is...
Calabresi, P. A (2004) Diagnosis and management of multiple sclerosis. FP Essent. 70: 1935-1944.
Soldan, S. S., G. Wu, C. Markowitz, and D. L. Kolson (2008). Multiple sclerosis and other demyelinating diseases. pp. 239-255. In: H. E. Gendelman, T. Ikezu (eds.). Neuroimmune Pharmacol. Springer, Boston, MA.
Singh, V., S. Mehrotra, and S. Agarwal (1999) The paradigm of Th1 and Th2 cytokines. J Immunol Res. 20: 147-161.
Weinshenker, B. G (1996) Epidemiology of multiple sclerosis. Neurol Clin. 14: 291-308.
Cree, B. A. C (2014) Multiple sclerosis genetics. Handb Clin Neurol. 122: 193-209.
Dhib-Jalbut S. and S. Marks (2010) Interferon- ${\beta}$ mechanisms of action in multiple sclerosis. Neurology 74: S17-S24.
Kieseier, B. C (2011) The Mechanism of action of interferon- ${\beta}$ in relapsing multiple sclerosis. CNS Drugs 25: 491-502.
Goldenberg, M. M (2012) Multiple Sclerosis Review. Pharmacol. Ther. 37: 175-184.
Beck, R. W., P. A. Cleary, J. D. Trobe, D. I. Kaufman, M. J. Kupersmith, D. W. Paty, C. H. Brown, and O. N. S. Group (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N. Engl. J. Med. 329: 1764-1769.
La Mantia, L., M. Eoli, C. Milanese, A. Salmaggi, A. Dufour, and V. Torri (1994) Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. Eur. Neurol. 34: 199-203.
Prisms, S (2001) PRISMS-4: Long-term efficacy of interferonbeta- 1a in relapsing MS. Neurology 56: 1628.
Paty, D., D. B. Li, U. M. M. S. Group, and I. M. S. S. Group (1993) Interferon beta?1b is effective in relapsing-remitting multiple sclerosis II. MRI analysis results of a multicenter, randomized, double?blind, placebo?controlled trial. Neurology 43: 662-662.
Simon, J. H., L. D. Jacobs, M. Campion, K. Simonian, N. Wende, D. L. Cookfair, R. A. Rudick, R. M. Herndon, J. R. Richert, and A. M. Salazar (1998) Magnetic resonance studies of intramuscular interferon ${\beta}$ -1a for relapsing multiple sclerosis. Ann Neurol. 43: 79-87.
Li, D. K., D. W. Paty, and UBC MS/MRI analysis research group (1999) Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon- ${\beta}$ 1 a in relapsing-remitting multiple sclerosis. Ann Neurol. 46: 197-206.
Rice, G., J. Oger, P. Duquette, G. S. Francis, M. Belanger, S. Laplante, and J. F. Grenier (1999) Treatment with interferon beta-1b improves quality of life in multiple sclerosis. Can. J. Neurol. Sci. 26: 276-282.
Sandig, V., T. Rose, K. Winkler, and R. Brecht (2005) Mammalian cells: Production of recombinant proteins: Novel microbial and eukaryotic expression systems, pp. 233-252. Wiley-VCH Weinheim, Germany,
Walsh, G (2014) Biopharmaceutical benchmarks 2014. Nat. Biotechnol. 32: 992-1000.
Aricescu, A. R. and R. J. Owens (2013) Expression of recombinant glycoproteins in mammalian cells: Towards an integrative approach to structural biology. Curr. Opin. Struct. Biol. 23: 345-356.
Zago, P., M. Baralle, Y. M. Ayala, N. Skoko, S. Zacchigna, E. Buratti, and S. Tisminetzky (2009) Improving human interferon- ${\beta}$ production in mammalian cell lines by insertion of an intronic sequence within its naturally uninterrupted gene. Biotechnol. Appl. Biochem. 52: 191-198.
Villela Dr. A., G. Renard, M. S. Palma, J. M. Chies, S. L. Dalmora, L. A. Basso, and D. S. Santos (2010) Human interferon Β1ser17: Coding DNA synthesis, expression, purification and characterization of bioactive recombinant protein. J. Microb. Biochem. Technol. 2: 1948-5948.
Mastrangeli, R., M. Rossi, M. Mascia, W. Palinsky, A. Datola, M. Terlizzese, and H. Bierau (2014) In vitro biological characterization of IFN- ${\beta}$ -1a major glycoforms. Glycobiology. 25: 21-29.
Han, Y. K., T. Y. Koo, and G. M. Lee (2009) Enhanced interferon- ${\beta}$ production by CHO cells through elevated osmolality and reduced culture temperature. Biotechnol. Prog. 25: 1440-1447.
Rodriguez, J., M. Spearman, N. Huzel, and M. Butler (2005) Enhanced Production of Monomeric Interferon- ${\beta}$ by CHO Cells through the Control of Culture Conditions. Biotechnol. Prog. 21: 22-30.
Spearman, M., J. Rodriguez, N. Huzel, K. Sunley, and M. Butler (2007) Effect of culture conditions on glycosylation of recombinant beta-interferon in CHO cells. pp. 71-85. In: Smith R. (eds) Cell Technology for Cell Products. Springer, Dordrecht, NL.
Spearman, M., J. Rodriguez, N. Huzel, and M. Butler (2005) Production and glycosylation of recobinant ${\beta}$ -interferon in suspension and cytopore microcarrier cultures of CHO cells. Biotechnol. Prog. 21: 31-39.
Song, K., I.S. Yoon, N. A. Kim, D. H. Kim, J. Lee, H. J. Lee, S. Lee, S. Choi , M. K. Choi, H. H. Kim, S. H. Jeong, and W. S. Son (2014) Glycoengineering of interferon- ${\beta}$ 1a improves its biophysical and pharmacokinetic properties. PloS ONE 9: e96967.
Mohan, C., Y. G. Kim, J. Koo, and G. M. Lee (2008) Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells. Biotechnol. J. 3: 624-630.
Lai, T., Y. Yang, and S. K. Ng (2013) Advances in mammalian cell line development technologies for recombinant protein production. Pharmaceuticals (Basel) 6: 579-603.
Kamionka, M. (2011) Engineering of therapeutic proteins production in Escherichia coli. Curr. Pharm. Biotechnol. 12: 268-274.
Rao, D. V. K., C. T. Ramu, J. V. Rao, M. L. Narasu, and A. K. S. B. Rao (2009) Cloning, high expression and purification of recombinant human Intereferon- ${\beta}$ -1b in Escherichia coli. Appl. Biochem. Biotechnol. 158: 140-154.
Harde, D. R., M. Knauf, and E. Croze (1995) The use of zwittergent 3-14 in the purification of recombinant human interferon- ${\beta}$ ser17 (Betaseron). J. Interferon Cytokine Res. 15: 31-37.
Ashnagar, F., M. Khodabandeh, A. Arpanaei, Z. A. Sadigh, F. Rahimi, and P. Shariati (2014) Optimizing primary recovery and refolding of human interferon-b from Escherichia coli inclusion bodies. Iran J. Biotechnol. 12: 26-34.
Sahdev, S., S. K. Khattar, and K. S. Saini (2008) Production of active eukaryotic proteins through bacterial expression systems: A review of the existing biotechnology strategies. Mol. Cell Biochem. 307: 249-264.
Skoko, N., B. Argamante, N. K. Grujicic, S. G. Tisminetzky, V. Glisin, and G. Ljubijankic (2003) Expression and characterization of human interferon- ${\beta}1$ in the methylotrophic yeast Pichia pastoris. Biotechnol. App.l Biochem. 38: 257-265.
Goffeau, A., B. G. Barrell, H. Bussey, R. W. Davis, B. Dujon, H. Feldmann, F. Galibert, J. D. Hoheisel, C. Jacq, M. Johnston, E. J. Louis, H. W. Mewes, Y. Murakami, P. Philippsen, H. Tettelin, and S. G. Oliver (1996) Life with 6000 genes. Science 274: 546-567.
Feizi, A., T. Osterlund, D. Petranovic, S. Bordel, and J. Nielsen (2013) Genome-scale modeling of the protein secretory machinery in yeast. PloS ONE 8: e63284.
Mattanovich, D., B. Gasser, H. Hohenblum, and M. Sauer (2004) Stress in recombinant protein producing yeasts. J. Biotechnol. 113: 121-135.
Mattanovich, D., P. Branduardi, L. Dato, B. Gasser, M. Sauer, and D. Porro (2012) Recombinant protein production in yeasts. pp. 329-358. In: Lorence A. (eds) Recombinant Gene Expression. Methods in Molecular Biology (Methods and Protocols). Humana Press, Totowa, NJ.
Arnold, S. and C. Scheckermann (2012) Method for the purification of interferon-B. US Patent, 424/85.6; 530/351.
Chernajovsky, Y., Y. Mory, L. Chen, Z. Marks, D. Novick, M. Rubinstein, and M. Revel (1984) Efficient constitutive production of human fibroblast interferon by hamster cells transformed with the IFN- ${\beta}1$ gene fused to an SV40 early promoter. DNA3: 297-308.
McCormick, F. R. A. N. K., M. Trahey, M. I. C. H. A. E. L. Innis, B. Dieckmann, and G. Ringold (1984) Inducible expression of amplified human beta interferon genes in CHO cells. Mol. Cell. Biol. 4: 166-172.
Romanov, V. P., V. V. Bezuglov, M. Y. Bobrov, T. I. Kostromina, S. A. Feofanov, and A. I. Miroshnikov (2011) Isolation of human interferon ${\beta}1b$ (Ser17) expressed in E. coli with the use of ion-exchange chromatography. Russ. J. Bioorganic. Chem. 37: 292-297.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.